Shares of the development-stage Catalyst Pharmaceuticals Inc. (CPRX) surged more than 51% to hit a 52-week high of $1.77 per share on Wednesday morning after the company announced positive top-line results from a clinical trial of its …
Oct 31 (Reuters) - Catalyst Pharmaceuticals Inc :Catalyst Pharmaceuticals completes enrollment in second Phase 3 trial of Firdapse® in patients with Lambert-Eaton Myasthenic Syndrome.Catalyst Pharmaceuticals Inc - ‍top-line results for …
LONDON (dpa-AFX) - The following are some of the biotech stocks that made their way onto the Day's Gainers & Losers' list of November 28, 2017. GAINERS 1. Apollo Endosurgery Inc. (APEN) Gained 33% to close Tuesday's (Nov.28) …
For now, the best news for investors may be that Fed members see no obvious cause for concern about the record-high U.S. stock market. The U.S. jobs report from July indicated that unemployment has dipped to its lowest level in 16 …